Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011)

被引:11
作者
Grossman, Douglas [1 ,4 ,5 ]
Farnham, James M. [3 ]
Hyngstrom, John [2 ,5 ]
Klapperich, Marki E. [7 ]
Secrest, Aaron M. [1 ]
Empey, Sarah [5 ]
Bowen, Glen M. [1 ,5 ]
Wada, David [1 ,5 ]
Andtbacka, Robert H. I. [2 ,5 ]
Grossmann, Kenneth [3 ,5 ]
Bowles, Tawnya L. [2 ]
Cannon-Albright, Lisa A. [3 ,5 ,6 ]
机构
[1] Univ Utah, Dept Dermatol, Hlth Sci Ctr, Salt Lake City, UT USA
[2] Univ Utah, Dept Surg, Hlth Sci Ctr, Salt Lake City, UT USA
[3] Univ Utah, Dept Med, Hlth Sci Ctr, Salt Lake City, UT 84112 USA
[4] Univ Utah, Dept Oncol Sci, Hlth Sci Ctr, Salt Lake City, UT USA
[5] Univ Utah, Huntsman Canc Inst, Hlth Sci Ctr, Salt Lake City, UT USA
[6] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT USA
[7] Univ Wisconsin Madison, Sch Med & Publ Hlth, Madison, WI USA
基金
美国国家卫生研究院;
关键词
melanoma; multiple primary; SEER; survival; RISK-FACTORS; CLINICOPATHOLOGICAL FEATURES; DIAGNOSIS; RATES;
D O I
10.1016/j.jaad.2018.02.055
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Survival data are mixed comparing patients with multiple primary melanomas (MPM) to those with single primary melanomas (SPM). Objectives: We compared MPM versus SPM patient survival using a matching method that avoids potential biases associated with other analytic approaches. Methods: Records of 14,138 individuals obtained from the Surveillance, Epidemiology, and End Results registry of all melanomas diagnosed or treated in Utah between 1973 and 2011 were reviewed. A single matched control patient was selected randomly from the SPM cohort for each MPM patient, with the restriction that they survived at least as long as the interval between the first and second diagnoses for the matched MPM patient. Results: Survival curves (n=887 for both MPM and SPM groups) without covariates showed a significant survival disadvantage for MPM patients (chi-squared 39.29, P<.001). However, a multivariate Cox proportional hazards model showed no significant survival difference (hazard ratio 1.07, P=.55). Restricting the multivariate analysis to invasive melanomas also showed no significant survival difference (hazard ratio 0.99, P=.96). Limitations: Breslow depth, ulceration status, and specific cause of death were not available for all patients. Conclusions: Patients with MPM had similar survival times as patients with SPM.
引用
收藏
页码:238 / 244
页数:7
相关论文
共 50 条
  • [41] Excision Margin and Survival in Patients with High-Risk, Primary Cutaneous Melanoma: A Retrospective Study Based on Surveillance Epidemiology and End Result (SEER) Database
    Xu, Meng-Nan
    Rao, Qiu
    DERMATOLOGY, 2022, 238 (03) : 534 - 541
  • [42] Based on the surveillance, epidemiology, and end results programme, to develop and validate nomograms for predicting overall survival and cancer-specific survival in geriatric patients with vulvar squamous cell carcinoma
    Qiu, Yuqi
    Wang, Sufei
    Yang, Jing
    Chen, Yong
    Wei, Hua
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2023, 44 (06) : 86 - 97
  • [43] Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database
    Mery, CM
    Pappas, AN
    Bueno, R
    Colson, YL
    Linden, P
    Sugarbaker, DJ
    Jaklitsch, MT
    CHEST, 2005, 128 (01) : 237 - 245
  • [44] Predictive Modelling of Overall Survival in Adult Patients with Primary Diffuse Large B-cell Lymphoma of the Breast Using the Surveillance, Epidemiology, and End Results (SEER) Database
    Liu, Yishuai
    Han, Haifeng
    Wei, Hong
    Wang, Xinlong
    Luan, Zhaotang
    Jiang, Kun
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2024, 19 (03) : 373 - 382
  • [45] A nomogram for predicting survival in patients with skin non-keratinizing large cell squamous cell carcinoma: A study based on the Surveillance, Epidemiology, and End Results database
    Zhang, Jinrong
    Yang, Wei
    Lian, Chengxiang
    Zhao, Qiqi
    Ming, Wai-kit
    Ip, Cheong Cheong
    Mu, Hsin-Hua
    Ching Tom, Kong
    Lyu, Jun
    Deng, Liehua
    FRONTIERS IN MEDICINE, 2023, 10
  • [46] Marital Status and Survival of Patients with Hormone Receptor-Positive Male Breast Cancer: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Study
    Liu, Lei
    Chi, Ya-Yun
    Wang, An-An
    Luo, Yonghui
    MEDICAL SCIENCE MONITOR, 2018, 24 : 3425 - 3441
  • [47] Disparities in survival for right-sided vs. left-sided colon cancers in young patients: a study based on the Surveillance, Epidemiology, and End Results database (1990-2014)
    Wang, Yaqi
    Yang, Lifeng
    Zhou, Menglong
    Shen, Lijun
    Zhang, Jing
    Deng, Weijuan
    Liang, Liping
    Hu, Ran
    Yang, Wang
    Yao, Ye
    Zhang, Zhen
    CANCER MANAGEMENT AND RESEARCH, 2018, 10 : 1735 - 1747
  • [48] Clinical Characteristics, Treatment, and Prognostic Factors of Patients With Primary Extramammary Paget's Disease (EMPD): A Retrospective Analysis of 44 Patients From a Single Center and an Analysis of Data From the Surveillance, Epidemiology, and End Results (SEER) Database
    Weng, Shanshan
    Zhu, Ning
    Li, Dan
    Chen, Yurong
    Tan, Yinuo
    Chen, Jiaqi
    Yuan, Ying
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [49] A comparison of the demographics, clinical features, and survival of patients with adenoid cystic carcinoma of major and minor salivary glands versus less common sites within the Surveillance, Epidemiology, and End Results registry
    Li, Nan
    Xu, Li
    Zhao, Hui
    El-Naggar, Adel K.
    Sturgis, Erich M.
    CANCER, 2012, 118 (16) : 3945 - 3953
  • [50] Nomograms predicting all-cause death and cancer-specific death in patients with bilateral primary breast cancer: a study based on Surveillance, Epidemiology, and End Results
    He, Mingyuan
    Hou, Yue
    Zou, Liqun
    Ran, Li
    BIOTECHNOLOGY AND GENETIC ENGINEERING REVIEWS, 2024, 40 (02) : 1136 - 1154